UPDATE : Wednesday, February 20, 2019
상단여백
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China
Samsung Bioepis said Monday that it has signed a licensing agreement with C...
by Lee Han-soo  |  2019-02-11 11:23
라인
Samsung BioLogics posts ￦535.8 billion in 2018 sales
Samsung BioLogics said Thursday that it recorded 535.8 billion won ($479 mi...
by Lee Han-soo  |  2019-02-01 11:56
라인
Celltrion to export biosimilars to Latin America
Celltrion Healthcare said Thursday that it has successfully won bids to sup...
by Lee Han-soo  |  2019-01-31 11:12
라인
Samsung Bioepis’ biosimilar sales in EU exceed $500 million
Samsung Bioepis’ biosimilar sales in European Union surpassed $500 million ...
by Lee Han-soo  |  2019-01-30 18:17
라인
KIST finds boiling histotripsy’s mechanism to remove tumor tissue
Local researchers have found how a boiling histotripsy worked to get rid of...
by Cho In-sung  |  2019-01-24 11:30
라인
FDA OKs Samsung Bioepis’ first oncology medicine
Samsung Bioepis said Monday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2019-01-21 11:43
라인
Celltrion wins patent dispute on Truxima
Celltrion said Friday that it has won the domestic patent appeal for chroni...
by Lee Han-soo  |  2019-01-18 11:47
라인
Over 1,000 bio-ventures set up in past 3 years
Korea’s bio-venture business boom peaked in 2016 and turned downward, but a...
by Lee Han-soo  |  2019-01-17 22:05
라인
CL Bio wins patent for substance that improves antidiabetic functions
CL Bio, a local biopharmaceutical firm, said Monday that it has acquired al...
by Lee Han-soo  |  2019-01-14 12:34
라인
Medipost, LG Chem to develop stem cell therapy
Medipost said Monday that it has signed a cooperation agreement with LG Che...
by Lee Han-soo  |  2019-01-08 17:55
라인
Samsung Bioepis to expand business in China
Samsung Bioepis has signed a licensing agreement with 3SBio, a Chinese biot...
by Lee Han-soo  |  2019-01-07 12:30
라인
Celltrion’s Truxima claims 35% of European rituximab market
Celltrion Healthcare said Thursday that Truxima (Ingredient: rituximab-abbs...
by Lee Han-soo  |  2019-01-04 15:54
라인
Alteogen wins patent on optimizing incubation conditions for Eylea biosimilar
Alteogen said Wednesday that it has registered a patent on quality improvem...
by Lee Han-soo  |  2019-01-03 16:01
라인
Newly listed pharmaceuticals suffer market cap declines
Market capitalizations of pharmaceutical and biotech companies that went pu...
by Nam Doo-hyun  |  2018-12-21 15:13
라인
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun  |  2018-12-17 12:48
라인
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun  |  2018-12-13 15:33
라인
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun  |  2018-12-12 16:27
라인
Samsung BioLogics, Celltrion shares soar despite uncertainty
The share prices of Samsung BioLogics and Celltrion rose Wednesday even tho...
by Lee Han-soo  |  2018-12-12 16:27
라인
Machine learning finds biomarker for rare Castleman Disease
Medidata, a cloud-based solution provider for clinical research, said it ha...
by Lee Hye-seon  |  2018-12-11 17:11
라인
Viromed finds prostate hyperplasia treatment effect in natural substance
A team of researchers at the Viromed’s natural product research group said ...
by Lee Han-soo  |  2018-12-11 14:55
-12345678910-
Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’
여백
Most viewed
여백
Opinion
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
여백
Back to Top